Join Now

Category Archives: Utah’s Life Sciences Companies

Turner Innovations Awarded STTR Phase 1 Contract from US Air Force

Turner Imaging Systems has won a small Business Technology Transfer (STTR) Phase I contract from the U.S. Air Force. Turner will use the non-dilutive funds to develop a next generation compact, highly portable, battery-powered full-body fluoroscopic X-ray (Smart-C) to help Special Operations Surgical Teams, Army Forward Surgical Teams (FSTs), and Navy Fleet Surgical Teams, save […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

Utah Life Sciences Companies Tout BioHive at Arab Health Trade Show

Organized by World Trade Center Utah and the Governor’s Office of Economic Development (GOED), eight Utah life sciences companies recently represented the state and our industry in Dubai, as part of the Arab Health trade show. The delegation exhibited in a booth showcasing the companies and BioHive. Quansys Biosciences, Turner Imaging Solutions and Zehn-X LLC, […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Tula Health Raises $24.1 Million, Valuation Rises to $187 Million

Tula Health recently raised $24.1 million in debt and equity financing from two venture firms – Springtide Ventures, a health tech venture firm based in Utah and Boston, and Sandbox Capital Advisors based in Salt Lake City. The company creates behavioral change guidance via on-call support, and supporting hardware and software to help their customers […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

nView s1 Reaches its 50th Surgery, Gets Navigation Capability

The nView s1, nView medical’s breakthrough imaging system, reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures. nView medical CEO, Cristian Atria, said, “To celebrate the 50th surgery milestone we gave the nView s1 […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

Launch of Xenter Therapeutics

Following the close of $12M in Series A funding, Xenter, Inc., the world’s first start-up Device-Data-Drug healthcare technologies company, announced the launch of the Xenter Therapeutics business unit. Xenter Therapeutics will lead the therapeutic drug element of Xenter’s mission and vision and is headed by President and Xenter board member David J. Bearss, PhD, a biotech […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

ARUP Celebrates Opening of a New State-of-the-Art Laboratory Facility in Salt Lake City

Founded in 1984, ARUP Laboratories, one of the nation’s largest reference laboratories, on Tuesday held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility located in University of Utah Research Park. The newly constructed facility is the crown jewel of eight properties ARUP now owns and operates as Research Park’s largest […]

Also posted in BioUtah News, State News, Utah's Life Sciences Companies | | Leave a comment

Renalytix Announces Leadership Additions for Expanding KidneyIntelX Deployment

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

How St. George Became the Epicenter for a Major Global Genetics Study

The St. George Chamber of Commerce recently held a special luncheon with a presentation by Travis Sheffield, operations director for Intermountain Precision Genomics on “How St. George Became the Epicenter for a Major Global Genetics Study”. Sheffield, who is leading the HerediGene Population Study throughout Utah, Idaho, and soon in Nevada, presented the ins and […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

Also posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

Also posted in BioUtah News, Industry News, Utah's Life Sciences Companies | | Leave a comment

Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]

Also posted in BioUtah News, Industry News, Utah's Life Sciences Companies | | Leave a comment